|
S
|
SHIRE BIOPHARMACEUTICALS HOLDINGS ActiveBusiness Services |
Financial statements of SHIRE BIOPHARMACEUTICALS HOLDINGS
According to SHIRE BIOPHARMACEUTICALS HOLDINGS latest financial report submitted on 2020-12-31, the company has a Total-Assets of £2B, Working-Capital of £214M while the EBITDA is -£567,199.17. Compared with the previous year, the company reported a Total-Assets increase of 0.22%, which is an equivalent of -3507987. At the same time, the Working-Capital went up by 1.22%, or by -2606625.
Turnover 2020
£ 0
-
Consolidated A/cs
N
-
Reporting period
12
-
Working Capital
£ 214.4 million
-
Profit after Tax
£ 2.6 million
SHIRE BIOPHARMACEUTICALS HOLDINGS Business Credit Report
A Business Credit Report for SHIRE BIOPHARMACEUTICALS HOLDINGS is available for instant download. The report will provide you with a credit score and credit limit recommendation for SHIRE BIOPHARMACEUTICALS HOLDINGS, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.
SHIRE BIOPHARMACEUTICALS HOLDINGS
SHIRE BIOPHARMACEUTICALS HOLDINGS Directors and key executives
View all employeesSHIRE BIOPHARMACEUTICALS HOLDINGS currently employs 2 people. Compared with the previous year, the company has reported a staff increase of 0%, which is an equivalent of 0 employees. In order to view contact information, including emails and phone numbers for all the employees working at SHIRE BIOPHARMACEUTICALS HOLDINGS and to export them in XL or to your existing CRM, you can subscribe to our platform here.
Total Employee Count
Total employees
2
100%
1y growth
Management Level
Middle
| Employee | Job Title | Phone | Country | |
|---|---|---|---|---|
| Mark Gibbons | Director |
-
|
- | GB |
| Nicholas Insall | Director |
-
|
- | GB |
| Chloe Spicer | Director |
-
|
- | GB |
| Peter Grubin | Director |
-
|
- | GB |
Get in touch with 4 of contacts working at SHIRE BIOPHARMACEUTICALS HOLDINGS
Upgrade to subscriptionSHIRE BIOPHARMACEUTICALS HOLDINGS Ownership and Group Structure
View full group structureSHIRE BIOPHARMACEUTICALS HOLDINGS is a subsidiary of TAKEDA PHARMACEUT**************** which is a holding company, with the following registration number 05492592. The holding group consists of a total of 63 companies, including SHIRE INTELLECTUAL PRO*********************, SHIRE HOLDINGS IREL*****************, NPS PHARMA INTERN***************, SHIRE PHARMACEUTICAL INVESTM***************************, SHIRE IRELAND P*************.
SHIRE BIOPHARMACEUTICALS HOLDINGS competitors:
View all competitorsTop 5 similar companies of SHIRE BIOPHARMACEUTICALS HOLDINGS are MACE GROUP LIMITED, ADMENTA HOLDINGS LIMITED, CHUGAI PHARMA EUROPE LIMITED, CIVICA HOLDINGS LIMITED, LENDLEASE CONSTRUCTION HOLDINGS (EUROPE) LIMITED. View and export all the competitor list of SHIRE BIOPHARMACEUTICALS HOLDINGS by upgrading your account here.
MACE GROUP LIMITED
ADMENTA HOLDINGS LIMITED
CHUGAI PHARMA EUROPE LIMITED
CIVICA HOLDINGS LIMITED
LENDLEASE CONSTRUCTION HOLDINGS (EUROPE) LIMITED
SHIRE BIOPHARMACEUTICALS HOLDINGS news & activities:
View full activityEBITDA
The SHIRE BIOPHARMACEUTICALS HOLDINGS-based company said the adjusted EBITDA is now -£567,199.17, compared with the previous year of 118.6 million.
uk.globaldatabase.com
2020-12-31
Employees
SHIRE BIOPHARMACEUTICALS HOLDINGS number of employees has decreased by 0% compared with previous year and now represents a total number of 2.
uk.globaldatabase.com
2020-12-31
Frequently Asked Questions regarding SHIRE BIOPHARMACEUTICALS HOLDINGS
Where is SHIRE BIOPHARMACEUTICALS HOLDINGS registered office?
SHIRE BIOPHARMACEUTICALS HOLDINGS is located at 1 KINGDOM STREET LONDON, United Kingdom.
What is the website of SHIRE BIOPHARMACEUTICALS HOLDINGS?
SHIRE BIOPHARMACEUTICALS HOLDINGS website is www.shire.com
How many people work at SHIRE BIOPHARMACEUTICALS HOLDINGS?
According to the latest account statement, there are currently 2 of employees working for SHIRE BIOPHARMACEUTICALS HOLDINGS.
What is SHIRE BIOPHARMACEUTICALS HOLDINGS EBITDA?
For 2020, SHIRE BIOPHARMACEUTICALS HOLDINGS has reported an EBITDA of -£567,199.17, which went down by -21009.43% compared to previous year.
What is the Business Credit Score of SHIRE BIOPHARMACEUTICALS HOLDINGS and how reliable is the company?
In order to check the business credit score of SHIRE BIOPHARMACEUTICALS HOLDINGS, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.
Does SHIRE BIOPHARMACEUTICALS HOLDINGS pay their invoices on time?
By requesting a Business Credit Report for SHIRE BIOPHARMACEUTICALS HOLDINGS, you will be able to gain more insights about the SHIRE BIOPHARMACEUTICALS HOLDINGS payment trends.
Who is the Ultimate Parent of the SHIRE BIOPHARMACEUTICALS HOLDINGS?
Information about the ultimate beneficial ownership TAKEDA PHARMACEUT**************** of SHIRE BIOPHARMACEUTICALS HOLDINGS is available when you order a business credit report.
Search for International Credit Report
|
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
